[What's new in the treatment of cancer pain?]
- PMID: 14975810
[What's new in the treatment of cancer pain?]
Abstract
Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant drug, for neuropathic pain; oral transmucosal fentanyl citrate for breakthrough pain; hydromorphone and oxycodone, morphine agonists, as an alternative to morphine; development of patient controlled analgesia via portable pump; better evaluation of alternative therapeutics.
Copyright John Libbey Eurotext 2003.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.Prescrire Int. 2002 Aug;11(60):106-7. Prescrire Int. 2002. PMID: 12199262
-
Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.J Pain Symptom Manage. 2008 May;35(5):563-7. doi: 10.1016/j.jpainsymman.2007.06.012. Epub 2008 Feb 6. J Pain Symptom Manage. 2008. PMID: 18258412
-
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.Clin Ther. 2007 Apr;29(4):588-601. doi: 10.1016/j.clinthera.2007.04.007. Clin Ther. 2007. PMID: 17617282 Clinical Trial.
-
[Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].Ann Fr Anesth Reanim. 2007 Jun;26(6):502-15. doi: 10.1016/j.annfar.2007.03.029. Epub 2007 Jun 8. Ann Fr Anesth Reanim. 2007. PMID: 17560755 Review. French.
Cited by
-
Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.PLoS One. 2017 Jun 27;12(6):e0179523. doi: 10.1371/journal.pone.0179523. eCollection 2017. PLoS One. 2017. PMID: 28654672 Free PMC article.
-
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain.Clinicoecon Outcomes Res. 2013 Dec 16;6:1-9. doi: 10.2147/CEOR.S52273. eCollection 2013. Clinicoecon Outcomes Res. 2013. PMID: 24368889 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical